Two Sigma Advisers
SCPH

Two Sigma Advisers’s scPharmaceuticals SCPH Stock Holding History

Two Sigma Advisers’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,000
Closed -$183K – 2558
2023
Q2 		$183K Sell
18,000
-121,700
-87% -$1.27M ﹤0.01% 2115
2023
Q1 		$1.27M Buy
139,700
+43,400
+45% +$318K ﹤0.01% 1510
2022
Q4 		$690K Buy
+96,300
New +$588K ﹤0.01% 1741
2021
Q3 		– Sell
-11,000
Closed -$67K – 2648
2021
Q2 		$67K Sell
11,000
-700
-6% -$4.22K ﹤0.01% 2369
2021
Q1 		$78K Sell
11,700
-1,300
-10% -$8.91K ﹤0.01% 2466
2020
Q4 		$69K Sell
13,000
-2,000
-13% -$15.7K ﹤0.01% 2298
2020
Q3 		$112K Buy
+15,000
New +$117K ﹤0.01% 2261

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return